Journal article icon

Journal article : Review

The assessment of antimalarial drug efficacy in vivo

Abstract:

Currently recommended methods of assessing the efficacy of uncomplicated falciparum malaria treatment work less well in high-transmission than in low-transmission settings. There is also uncertainty how to assess intermittent preventive therapies and seasonal malaria chemoprevention (SMC), and Plasmodium vivax radical cure. A pharmacometric antimalarial resistance monitoring (PARM) approach is proposed specifically for evaluating slowly eliminated antimalarial drugs in areas of high transmission. In PARM antimalarial drug concentrations at recurrent parasitaemia are measured to identify outliers (i.e., recurrent parasitaemias in the presence of normally suppressive drug concentrations) and to evaluate changes over time. PARM requires characterization of pharmacometric profiles but should be simpler and more sensitive than current molecular genotyping-based methodologies. PARM does not require parasite genotyping and can be applied to the assessment of both prevention and treatment.

Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.pt.2022.05.008

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Role:
Author
ORCID:
0000-0002-1897-1978



Publisher:
Cell Press
Journal:
Trends in Parasitology More from this journal
Volume:
38
Issue:
8
Pages:
660-672
Publication date:
2022-06-06
Acceptance date:
2022-05-16
DOI:
EISSN:
1471-5007
ISSN:
1471-4922
Pmid:
35680541


Language:
English
Keywords:
Subtype:
Review
Pubs id:
1263942
Local pid:
pubs:1263942
Deposit date:
2023-11-20
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP